Thx Matt, re the $1.5m / quarter additional revenue figure that we can look forward to, from Q2 FY18 onwards.
Yes, I noticed that 2019 date for going CF+ in Paterson's Research Note. A bit of an anomaly in that these broker reports are usually stupidly optimistic in their numbers...
Perhaps of note is that this estimate makes no allowance for sales of 3D (or any new hospital contracts).
Personally I'm happy to go with the Code Red projections for the moment...but we all wait expectantly for a FY18 projection update by the company (late July/August?).
Thx Matt, re the $1.5m / quarter additional revenue figure that...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |